BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou F, Xu Y, Shi J, Lan X, Zou X, Wang L, Huang Q. Expression profile of E-cadherin, estrogen receptors, and P53 in early-onset gastric cancers. Cancer Med. 2016;5:3403-3411. [PMID: 27781410 DOI: 10.1002/cam4.931] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Zhou F, Xu Y, Shi J, Lan X, Zou X, Wang L, Huang Q. Expression profile of E-cadherin, estrogen receptors, and P53 in early-onset gastric cancers. Cancer Med. 2016;5:3403-3411. [PMID: 27781410 DOI: 10.1002/cam4.931] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
2 Aghajani MJ, Yang T, Schmitz U, James A, McCafferty CE, de Souza P, Niles N, Roberts TL. Epithelial-to-mesenchymal transition and its association with PD-L1 and CD8 in thyroid cancer. Endocr Connect 2020;9:1028-41. [PMID: 33112841 DOI: 10.1530/EC-20-0268] [Reference Citation Analysis]
3 Yang X, Guo Y, He J, Zhang F, Sun X, Yang S, Dong H. Estrogen and estrogen receptors in the modulation of gastrointestinal epithelial secretion. Oncotarget 2017;8:97683-92. [PMID: 29228643 DOI: 10.18632/oncotarget.18313] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
4 Ge H, Yan Y, Tian F, Wu D, Huang Y. Prognostic value of estrogen receptor α and estrogen receptor β in gastric cancer based on a meta-analysis and The Cancer Genome Atlas (TCGA) datasets. Int J Surg 2018;53:24-31. [PMID: 29555527 DOI: 10.1016/j.ijsu.2018.03.027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
5 Iida Y, Hongo K, Onoda T, Kita Y, Ishihara Y, Takabayashi N, Kobayashi R, Kuriki K, Hiramatsu T. Long-term response on letrozole for gastric cancer: A case report. Medicine (Baltimore) 2021;100:e26146. [PMID: 34032767 DOI: 10.1097/MD.0000000000026146] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Baiocchi GL, Molfino S, Baronchelli C, Giacopuzzi S, Marrelli D, Morgagni P, Bencivenga M, Saragoni L, Vindigni C, Portolani N, Botticini M, De Manzoni G. Recurrence in node-negative advanced gastric cancer: Novel findings from an in-depth pathological analysis of prognostic factors from a multicentric series. World J Gastroenterol 2017;23:8000-7. [PMID: 29259375 DOI: 10.3748/wjg.v23.i45.8000] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 George S, Lucero Y, Torres JP, Lagomarcino AJ, O'Ryan M. Gastric Damage and Cancer-Associated Biomarkers in Helicobacter pylori-Infected Children. Front Microbiol 2020;11:90. [PMID: 32117120 DOI: 10.3389/fmicb.2020.00090] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
8 Ailiken G, Kitamura K, Hoshino T, Satoh M, Tanaka N, Minamoto T, Rahmutulla B, Kobayashi S, Kano M, Tanaka T, Kaneda A, Nomura F, Matsubara H, Matsushita K. Post-transcriptional regulation of BRG1 by FIRΔexon2 in gastric cancer. Oncogenesis 2020;9:26. [PMID: 32071290 DOI: 10.1038/s41389-020-0205-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
9 Li J. Gastric Cancer in Young Adults: A Different Clinical Entity from Carcinogenesis to Prognosis. Gastroenterol Res Pract 2020;2020:9512707. [PMID: 32190044 DOI: 10.1155/2020/9512707] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
10 Obulkasim H, Shi X, Wang J, Li J, Dai B, Wu P, Wang S, Wang X, Ding Y. Podoplanin is an important stromal prognostic marker in perihilar cholangiocarcinoma. Oncol Lett 2018;15:137-46. [PMID: 29391878 DOI: 10.3892/ol.2017.7335] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]